Denali Therapeutics Inc. Stock Forecast
Red day on Monday for Denali Therapeutics Inc. stock after losing 2.30%
(Updated on Apr 15, 2024)
The Denali Therapeutics Inc. stock price fell by -2.30% on the last day (Monday, 15th Apr 2024) from $18.26 to $17.84. During the last trading day the stock fluctuated 3.27% from a day low at $17.71 to a day high of $18.29. The price has fallen in 7 of the last 10 days and is down by -13.23% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -174 thousand shares and in total, 909 thousand shares were bought and sold for approximately $16.22 million.
Given the current short-term trend, the stock is expected to rise 17.17% during the next 3 months and, with a 90% probability hold a price between $20.90 and $29.67 at the end of this 3-month period.
DNLI Signals & Forecast
There are few to no technical positive signals at the moment. The Denali Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $18.79 and $20.02. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, February 27, 2024, and so far it has fallen -23.60%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Denali Therapeutics Inc. stock
Denali Therapeutics Inc. finds support from accumulated volume at $17.20 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.580 between high and low, or 3.27%. For the last week, the stock has had daily average volatility of 4.26%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (DNLI) For The Upcoming Trading Day Of Tuesday 16th
For the upcoming trading day on Tuesday, 16th we expect Denali Therapeutics Inc. to open at $17.95, and during the day (based on 14 day Average True Range), to move between $16.85 and $18.83, which gives a possible trading interval of +/-$0.99 (+/-5.53%) up or down from last closing price. If Denali Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 11.06% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $17.20 (3.59%) than the resistance at $20.13 (12.84%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Denali Therapeutics Inc. stock A Buy?
The Denali Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Denali Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
Current score: -1.232 Sell Candidate Unchanged
Predicted Opening Price for Denali Therapeutics Inc. of Tuesday, April 16, 2024
| Fair opening price April 16, 2024 | Current price |
|---|---|
| $17.95 ( 0.598%) | $17.84 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for DNLI
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 18.53 | 3.85 % | |
| R2 | 18.31 | 2.61 % | ||
| R1 | 18.17 | 1.84 % | ||
| Current price: | 17.84 | |||
| Support | S1 | 17.73 | -0.644 % | |
| S2 | 17.59 | -1.41 % | ||
| S3 | 17.37 | -2.65 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 20.52 | 15.02 % | |
| R2 | 20.21 | 13.28 % | ||
| R1 | 20.13 | 12.84 % | ||
| Current price | 17.84 | |||
| Support | S1 | 17.20 | -3.59% | |
| S2 | 17.02 | -4.60% | ||
| S3 | 16.01 | -10.26% |
FAQ
Click here for our free guide on how to buy Denali Therapeutics Inc. Stock.
